Nanoparticle delivery systems for HIV pre-exposure prophylaxis (PrEP): advances and challenges
Beilstein Journal of Nanotechnology · 07.07.2026 · 17 · 839-853
DOI: 10.3762/bjnano.17.60 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Beilstein Journal of Nanotechnology, online erschienen am 07.07.2026. Verfasst von Sonia Zahara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Chemistry and The Photonics Center, Boston University, Boston, MA 02215, United States. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
HIV pre-exposure prophylaxis (PrEP) encompasses antiviral drugs or formulations that aim to prevent the establishment of a permanent infection if exposure occurs. Conventional oral PrEP approaches require a daily drug regimen for effective prophylaxis, which can become burdensome, and pill fatigue creates challenges for adherence. There is, consequently, interest in the development of long-acting formulations of antiretrovirals that provide protection over extended periods of time after a single treatment. Nanoformulations and nanoparticle delivery strategies play an important role in achieving long acting (LA)-PrEP. This manuscript reviews emerging nanoparticle delivery platforms for LA-PrEP with a particular focus on four distinct classes of nanomaterials, namely, polymeric nanoparticles, lipid-based nanoparticles, inorganic nanoparticles, and hybrid nanoparticles. Nanoparticle design considerations and targeting strategies for the individual classes are examined, and the opportunities and challenges for the different nanomaterials approaches in the context of LA-PrEP are discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dept. of Chemistry and The Photonics Center, Boston University, Boston, MA 02215, United States.
ORCID-Profile: Sonia Zahara, Björn M Reinhard
Förderung
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Zahara, S., & Reinhard, B. M. (2026). Nanoparticle delivery systems for HIV pre-exposure prophylaxis (PrEP): advances and challenges. Beilstein Journal of Nanotechnology, 17, 839-853. https://doi.org/10.3762/bjnano.17.60
Vancouver
Zahara S, Reinhard BM. Nanoparticle delivery systems for HIV pre-exposure prophylaxis (PrEP): advances and challenges. Beilstein Journal of Nanotechnology. 2026;17:839-853. doi:10.3762/bjnano.17.60
BibTeX
@article{Zahara2026,
author = {Zahara, Sonia and Reinhard, Björn M},
title = {Nanoparticle delivery systems for HIV pre-exposure prophylaxis (PrEP): advances and challenges},
journal = {Beilstein Journal of Nanotechnology},
year = {2026},
volume = {17},
pages = {839--853},
doi = {10.3762/bjnano.17.60}
}
EUVIMED